00:00Regeneron Pharmaceuticals surged 13.30% today.
00:04What happened?
00:06Regeneron develops and sells medicines for conditions including inflammatory diseases,
00:12serious eye disorders, and cancer.
00:15The move came after Regeneron reported stronger-than-expected third-quarter results.
00:22In an SEC filing, the company said non-GAAP earnings reached $20.07 per share,
00:28compared with an estimate of $16.48.
00:33The filing also highlighted growth across several major medicines
00:37and an expanded collaboration with Sanofi.
00:41Put together, the earnings beat and operating update
00:44gave investors concrete new information to reprice the stock during today's session.
00:51Healthcare rose 0.47% today, so this went much further than the sector did.
00:58A new post-market recap every trading day.
